ÇEVİK, M. Et Al. 2015. The role of Apolipoprotein B polymorphisms in essential hypertension. 1st Pharmacogenomics İstanbul Summit: Increasing the Safety and Effectivness of Personalized therapy for Metabolic Disorders , (Turkey).

ÇEVİK, M., KOLDEMİR GÜNDÜZ, M., ÇAĞATAY, P., ÇİFTÇİ, Ç., & SÜSLEYİCİ DUMAN, B., (2015). The role of Apolipoprotein B polymorphisms in essential hypertension . 1st Pharmacogenomics İstanbul Summit: Increasing the Safety and Effectivness of Personalized therapy for Metabolic Disorders, Turkey

ÇEVİK, MEHTAP Et Al. "The role of Apolipoprotein B polymorphisms in essential hypertension," 1st Pharmacogenomics İstanbul Summit: Increasing the Safety and Effectivness of Personalized therapy for Metabolic Disorders, Turkey, 2015

ÇEVİK, MEHTAP Et Al. "The role of Apolipoprotein B polymorphisms in essential hypertension." 1st Pharmacogenomics İstanbul Summit: Increasing the Safety and Effectivness of Personalized therapy for Metabolic Disorders , Turkey, 2015

ÇEVİK, M. Et Al. (2015) . "The role of Apolipoprotein B polymorphisms in essential hypertension." 1st Pharmacogenomics İstanbul Summit: Increasing the Safety and Effectivness of Personalized therapy for Metabolic Disorders , Turkey.

@conferencepaper{conferencepaper, author={MEHTAP ÇEVİK Et Al. }, title={The role of Apolipoprotein B polymorphisms in essential hypertension}, congress name={1st Pharmacogenomics İstanbul Summit: Increasing the Safety and Effectivness of Personalized therapy for Metabolic Disorders}, city={}, country={Turkey}, year={2015}}